European Journal of Medicinal Chemistry · 2021 · 51 citations · 44 references
Life SciencesBiochemistryMedicinal ChemistryDementiaDrug DiscoveryNeurodegenerationAlzheimer DiseaseMolecular Basis Of NeurodegenerationNeurodegenerative DiseasesNeurodegenerative DisordersProteolytic EnzymesProteolytic ProcessingAlzheimer Disease NeuroprotectionAmyloid Beta PeptidesPharmacological Treatment Of Dementia
44
Kathleen M. Sakamoto, Kyung B. Kim, Akiko Kumagai et al. · Proceedings of the National Academy of Sciences · 2001 · 2.5K citations · Full text
<scp>2021</scp> Alzheimer's disease facts and figures
Alzheimer s & Dementia · 2021 · 2.2K citations
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway, Reisa A. Sperling, Nick C. Fox et al. · New England Journal of Medicine · 2014 · 2K citations · Full text
Medicine, Neurology, Pharmacology +17
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text
Medicine, Neurology, Neuroscience +14